Hextend® is a sterile medical IV solution used as a blood plasma volume expander to replace blood volume lost in routine surgery, emergency trauma surgery and other applications, a condition known as hypovolemia (low blood volume). Hextend’s unique formulation contains a modified form of starch (6% hetastarch) suspended in a balanced electrolyte solution. The product more closely mirrors the electrolyte balance of blood than other products that contain 6% hetastarch in simple salt (sodium chloride, or saline) solutions. Hextend is not a substitute for blood or plasma.
Please see the Hextend Product Insert for complete prescribing information.
Hextend®is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ Healthcare Corporation, under exclusive licensing agreements.